Augmented-Reality Visual Cues for Parkinson's Disease

Phase-Based Progress Estimates
Cleveland Clinic Foundation, Cleveland, OHParkinson's Disease+5 MoreExaminer-triggered - Other
All Sexes
What conditions do you have?

Study Summary

This trial will test how effective augmented-reality (AR) glasses are at helping people with Parkinson's Disease reduce their gait freezing (FOG) by providing digital cues that only the wearer can see.

Eligible Conditions
  • Parkinson's Disease
  • Neurologic Gait Disorders
  • Movement Disorders
  • Gait Instability
  • Festinating Gait

Treatment Effectiveness

Study Objectives

2 Primary · 6 Secondary · Reporting Duration: For each arm, during the single-day research visit only.

For each arm, during the single-day research visit only.
Freezing Index
Mean Stride Length
Number of Freeze Episodes
Percent Time Freezing
Step Cadence
Stride Time Coefficient of Variation
Gait, Unsteady

Trial Safety

Trial Design

1 Treatment Group

Augmented-Reality Visual Cues
1 of 1

Experimental Treatment

36 Total Participants · 1 Treatment Group

Primary Treatment: Augmented-Reality Visual Cues · No Placebo Group · N/A

Augmented-Reality Visual CuesExperimental Group · 6 Interventions: Examiner-triggered, No Cue, Conventional Cue, Constant Cue, Patient hand-triggered, Patient eye-triggered · Intervention Types: Other, Other, Other, Other, Other, Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: for each arm, during the single-day research visit only.

Who is running the clinical trial?

American Parkinson's Disease Association, IncOTHER
2 Previous Clinical Trials
47 Total Patients Enrolled
The Cleveland ClinicLead Sponsor
959 Previous Clinical Trials
1,364,027 Total Patients Enrolled
James Liao, MD PhDPrincipal InvestigatorThe Cleveland Clinic

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have been diagnosed with Parkinson's disease by a doctor.

Frequently Asked Questions

What are the chief ambitions of this clinical experiment?

"This clinical trial aims to measure Percent Time Freezing over the course of a single-day research visit. Secondary outcomes include Step Cadence, an index derived from body-worn wireless sensors that serves as an indicator of dysfunction; Freezing Index, another marker determined by kinematic recordings taken with these sensors; and Gait Velocity which is also indicative of gait disorder due to its correlation with sensor readings." - Anonymous Online Contributor

Unverified Answer

Is enrollment available for this clinical trial at present?

"The details available on suggest that this medical trial is not presently seeking participants, as the last update was posted on November 4th 2022. Nonetheless, there are 1539 other trials actively recruiting patients at present." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.